PEMF Therapy - FDA Approved

 In 1979, the FDA approved PEMF Therapy for the healing of nonunion fractures.

In 1998, the FDA approved PEMF Therapy for urinary incontinence and muscle stimulation.

In 2004, the FDA approved PEMF Therapy for cervical fusion patients at high-risk of non-fusion.

In 2006, the FDA approved PEMF Therapy for treatment of depression and anxiety.

In 2011, the FDA approved PEMF Therapy for treatment of brain cancer.

On October 13th, 2015, the FDA reclassified PEMF devices from their existing Class 3 category to a Class 2 status, and most PEMF devices that are sold today in the United States are FDA registered as wellness devices.